$EPGL Stock buy or sell?

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Facing the Class Action Deadline There's nothing like a looming deadline to stir the pot, and that's exactly what's happening with D-Wave Quantum Inc. (NASDAQ: QBTS) as it faces the heat of a class action lawsuit. Investors who got caught in the slide between February 26, 2026, and August 25, 2026, need to sharpen their pencils and mark December 15, 2026, on their...

The Collagen Market: A Growing Landscape The collagen market is undergoing an impressive transformation, with estimates suggesting it will reach around USD 22.7 billion in the coming years. As of 2023, the market is valued at approximately USD 9.8 billion and is set for a compound annual growth rate (CAGR) of 9.8% from 2024 to 2032. This growth is propelled by increasing...

Enfusion Reports Impressive Third Quarter Financial Results Enfusion, Inc. (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions tailored for investment managers, has released its financial results for the third quarter of 2024. These results were included in a detailed Shareholder Letter accessible through their Investor Relations platform. Quarterly...

Uneven Terrain for Entrepreneur Universe Bright Group Try strapping in for a roller coaster ride with this latest release from Entrepreneur Universe Bright Group. Revenue took a dive, yet they clapped for themselves for keeping some coin in the bank. For the second quarter of 2026, we saw revenue drop like a lead balloon—to $746,113 from last year’s $1,143,106. Now if...

Koii Network ($KOII) Begins Trading on Prominent Exchanges Following a highly successful mainnet launch along with multiple oversubscribed token sales, Koii Network ($KOII) has officially started trading on Gate.io and MEXC. This initiative marks a significant milestone, showcasing the power of the World's Biggest Supercomputer that emphasizes decentralized computing....

Anticipated Earnings Call for Bullish Bullish (BLSH) is poised to share its earnings results for the upcoming quarter following the market close. Investors and analysts alike are keenly observing this release as it promises valuable insights into the company's financial health. Expected Financial Performance Analysts predict that the company will report a quarterly loss...